# Thomas E. Witzig

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/thomas-e-witzig/

## Facts

| Field | Value |
| --- | --- |
| Citations | 62,755 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 131 |
| i10-index | 549 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5004152557 |
| ORCID iD | https://orcid.org/0000-0002-4215-6500 |
| Works | 1,274 |

## Researcher papers

- [International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease](https://scholariq.org/papers/international-consensus-guidance-statement-on-the-management-and-treatment-of/)
- [Rituximab for IgG4-related disease: a prospective, open-label trial](https://scholariq.org/papers/rituximab-for-igg4-related-disease-a-prospective-open-label-trial/)
- [Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience](https://scholariq.org/papers/treatment-of-relapsing-autoimmune-pancreatitis-with-immunomodulators-and/)
- [Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma](https://scholariq.org/papers/safety-of-yttrium-90-ibritumomab-tiuxetan-radioimmunotherapy-for-relapsed-low/)
- [Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy](https://scholariq.org/papers/phase-iii-randomized-double-blind-study-of-epoetin-alfa-compared-with-placebo-in/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.